1. Introduction {#s0005}
===============

The World Health Organization (WHO) recommends that each patient-physician encounter should be utilized to determine the patient\'s vaccination status ([@bb0310], [@bb0160]). In an effort to harmonize vaccination records for international travel, the WHO has issued the *International Certificate of Vaccination or Prophylaxis* (WHO-ICV), sometimes referred to as "the yellow card" ([@bb0415]).

In many European countries, centralized vaccination registries are not available, but parents are maintaining a paper-based vaccination record for their children at home ([@bb0375]). In Germany, the WHO-ICV is used as the standard vaccination record, where any routine, special indication and travel vaccines are documented ([@bb0375], [@bb0245]). Parents rushing their children to the emergency department (ED) however, often forget to bring the WHO-ICV with them ([@bb0130]). Pediatricians and surgeons may require the information in the acute care situation ([@bb0215], [@bb0045]). In these instances, the parents will be asked to remember which vaccines have been administered to their children ("parental recall") ([@bb0405]). The most common answer during verbal immunization histories is that the children have received "the usual vaccines". Further details are often inaccessible ([@bb0230]).

The European Centre for Disease Prevention and Control (ECDC) as well as the VENICE project keep track on vaccination rates in different EU member states ([@bb0395], [@bb0205]). According to ECDC, German vaccination rates are lower than in many other European countries ([@bb0390]). A recent global survey of vaccine acceptance around the world revealed that Europe is in fact the WHO region with the lowest vaccine acceptance ([@bb0190]). Germany is one of the countries with significant issues in this area. As a result, vaccine-preventable diseases (VPD) are still posing a health risk to children in Germany today. For example, the prevalence of measles infections remained high during the past decade, despite the universal recommendation and availability of measles vaccines ([@bb0250]). Disease outbreaks are the consequence ([@bb0315], [@bb0280]).

The combat against VPD would benefit from empowered parents, who are able to provide detailed and accurate vaccination histories and who are in a position to interpret what has been documented in the vaccination record ([@bb0320]). Scientific studies assessing the ability of lay people to understand and report the content of a WHO-ICV however, are lacking ([@bb0220]).

To enable parents to report accurate vaccination histories, the Vienna Vaccine Safety Initiative (ViVI) has developed a digital vaccine education and empowerment tool (*VAccApp*) to be used on smartphones or tablet computers ([@bb0210], [@bb0255], [@bb0330]). The *VAccApp* was designed to invite parents to take a look at the WHO-ICV and to engage in a virtual dialogue covering all aspects of vaccines administered to their children, thereby making parents an active partner in protecting their family. The development of this educational intervention was informed by the data gathered from a separate group of parents, who tried to remember the vaccination status of their child in the absence of a vaccination record ("Recall Group").

The verbal immunization histories generated awareness of knowledge gaps among parents and additional insight into how parents are remembering different kinds of vaccination events. This feedback was leveraged to create a user-friendly mobile application. The reported validation project was thus designed to assess the *status quo* and to test a practical means for improving the *status quo* using a beta version of the *VAccApp*. We are presenting the results of a validation study testing the *VAccApp* in the typical user-group of parents waiting for their child to be seen at a pediatric emergency room in Berlin, Germany. To the author'\'s knowledge no similar educational tools have been developed so far. Different applications and text message services for appointment reminders have shown promising results in increasing the vaccination rate among users but did not test the knowledge of parents regarding the vaccination status of their children ([@bb0285], [@bb0350], [@bb0400]).

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

The validation project was conducted from March 2012--August 2014 in the context of quality management (QM) programs at the Charité Department of Pediatrics in collaboration with the Robert Koch Institute in Berlin, Germany, as described previously ([@bb0305], [@bb0080], [@bb0175], [@bb0265], [@bb0365]). Infants and children (0--18 years of age) presenting to the ED or hospitalized with suspected vaccine-preventable diseases (e.g. influenza-like illness or infections of the central nervous system) participated in QM programs approved by the institutional review board (IRB, EA24/008/10, EA2/161/11). Their parents were eligible for *VAccApp* user-testing. Informed consent procedures were waived by the IRB for the purpose of quality improvement.

2.2. Standard operating procedure (SOP) {#s0020}
---------------------------------------

According to the QM SOP, vaccination records were solicited from all patients participating in the QM program. When the WHO-ICV was available, a photocopy was obtained for manual data entry into an anonymized PostgreSQL database, performed by an independent data entry professional, followed by double-entry verification (gold standard).

When vaccination records were *not* available (in approximately 74% of cases) trained QM staff conducted structured interviews, asking the parents about the vaccination status for every VPD separately (i.e. "Was your child ever vaccinated against rotavirus?" --- Yes/No/I do not know). After completion of the interview, parents were asked to hand in the WHO-ICV later, for a photocopy and professional data entry ("Recall Group").

From January 2014--August 2014, those parents who were fluent in German and who had brought their WHO-ICV with them, were invited to transfer the information (as they understood it) from the WHO-ICV into the *VAccApp* ("*VAccApp* Group").

Professional data entry from the same vaccination record served as the gold standard for the quality of data obtained with the *VAccApp*. Likewise, the quality of data obtained from verbal immunization histories in the absence of a vaccination record was compared to the gold standard, i.e. professional data entry from a vaccination record later provided by the parents.

Both the structured interview as well as the *VAccApp* solicited the same basic information regarding 25 different vaccine types.

The *VAccApp* also contained a brief pre/post testing feature, assessing potential short-term learning effects resulting from *VAccApp* utilization: Initially, participants were asked to remember off-record, whether their child had ever received any of three commonly used childhood immunizations. The same question was repeated immediately after *VAccApp* utilization. The pre/post testing had to be completed without consulting the WHO-ICV or the *VAccApp*.

After using the *VAccApp*, parents were also invited to provide a feedback regarding the mobile application itself, using a standard instrument, the so-called System Usability Scale ([@bb0040], [@bb0025]). The System Usability Score consists of ten statements (e.g. "I felt very confident using the app"), which are judged by the user on a five point Likert scale. Scores are reported ranging from 0 ("worst imaginable") to 100 ("best imaginable") ([@bb0040], [@bb0025]).

2.3. *VAccApp* design {#s0025}
---------------------

The *VAccApp* was designed to help parents understand the vaccination record of their children. The mobile application was developed by ViVI, a Berlin-based vaccine safety think tank and non-profit organization, in collaboration with the School of Design Thinking in Potsdam, Germany ([@bb0330]). Design Thinking is an innovation technique first taught at Stanford University with a strong focus on user-centeredness and interdisciplinary thought processes ([@bb0210]). The visual language of the *VAccApp* is non-threatening and playful, using graphical representations of health care practitioners and vaccine recipients (avatars) keeping the user engaged.

For the purposes of the QM program, the *VAccApp* beta version was provided on *Google Nexus 7 Tablets™* as a mobile application for *Android* systems ([@bb0330]). During the evaluation period, the *VAccApp* remained on the tablet computers provided by QM staff. Parents entered the requested information autonomously and anonymously while waiting for their child to be seen by a doctor.

When using the *VAccApp*, parents were instructed to open the vaccination record and to look up any of the requested information in the WHO-ICV. The questions in the App were presented by avatars representing either a physician or a nurse, asking for example "Is your child vaccinated against tetanus?" ([Fig. 1](#f0005){ref-type="fig"})

After the initial yes/no/unknown response, the avatar assisted the user in localizing pertinent information in the WHO-ICV and on product labels. Parents could also enter the name and number of immunizations received, including booster vaccinations, batch numbers, and vaccination dates. The queries were repeated for every vaccine type separately (named after the respective VPD), including special indication and travel vaccines.

2.4. Statistical analysis {#s0030}
-------------------------

Descriptive analyses were executed using Microsoft Excel 14.0.7 and basic statistical analyses with IBM SPSS Statistics 22.

[Table 1](#t0005){ref-type="table"} illustrates the demographic characteristics of patients participating in the *VAccApp* Group compared to the Recall Group. *P*-values were computed using the Whitney *U* test and the Chi-square test to assess whether the groups were significantly different from each other.

Responses from the structured interview and *VAccApp* entries were both compared to gold standard, i.e. professional data entry from photocopies of the respective WHO-ICV. Bivariate statistical analysis was performed, assessing the percentage of parents able to provide a complete vaccination history (i.e. with 25/25 correct answers) in either group (*VAccApp* and Recall Group).

Overall accuracy rates were expressed as the percentage of the 25 vaccine questions in the *VAccApp* or structured interview, which a parent had been able to answer correctly.

In addition, vaccine-specific accuracy rates were computed for each vaccine type separately, and expressed as the proportion of parents providing accurate responses with either the *VAccApp* or during structured interviews.

For the pre/post testing, the percentage of accurate responses before and after *VAccApp* utilization was compared using the Chi-square test.

3. Results {#s0035}
==========

3.1. Baseline characteristics {#s0040}
-----------------------------

464 parents had initially brought the vaccination record with them. Of these, 178 parents participated in the program, completing the user-testing of the *VAccApp* (*VAccApp* Group). Ten parents declined participation. The remaining 276 parents were unable to participate in the user-testing due to lack of time or language skills.

A total of 278 parents did not have the vaccination record initially but were able to provide it at a later time (Recall Group) for comparison between parental recall and the same gold standard (professional data entry).

The composition of the *VAccApp* Group and the Recall Group is described in detail in [Table 1](#t0005){ref-type="table"}. The two groups differed significantly with respect to mean patient age and ethnicity: children in the *VAccApp* Group were younger, and more participants in the *VAccApp* Group identified as Caucasian (*p* \< 0.001 and *p* = 0.048, respectively). The remaining baseline characteristics were comparable between groups.

3.2. Overall and vaccine-specific accuracy rates in the Recall Group {#s0045}
--------------------------------------------------------------------

Having no WHO-ICV at hand, 9.0% of parents in the Recall Group provided a complete and fully accurate vaccination status (responding to 25/25 questions correctly). On average, 39.2% of the questions were answered correctly. Additional detail was not requested in the Recall Group. The majority of parents in the Recall Group (82.7%) indicated that their children were up-to-date on recommended immunizations, but when asked to respond to vaccine-specific questions, 41.7% parents responded with "I do not know" to at least 24 out of 25 vaccine questions. Accuracy rates varied by vaccine type ([Table 2](#t0010){ref-type="table"}) and ranged from 23.7% for meningococcal vaccine to 69.1% for influenza.

3.3. Overall accuracy rates and vaccine-specific accuracy rates in the *VAccApp* Group {#s0050}
--------------------------------------------------------------------------------------

With the help of the *VAccApp* and the vaccination record, 61.8% of participants were able to provide a fully accurate vaccination status. An average of 24/25 (95.2%) accurate responses was achieved. When asked to provide additional detail, such as the number of vaccine doses administered and the dates of administration, accuracy rates declined progressively, but 25% of *VAccApp* users were able to provide all additional detail accurately. Vaccine-specific accuracy rates ranged from 85.4% for meningococcal vaccine to 100% for special indication and travel vaccines such as cholera, typhoid fever, rabies and Japanese encephalitis vaccines ([Table 3](#t0015){ref-type="table"}).

3.4. Learning effects and usability score {#s0055}
-----------------------------------------

The pre/post testing revealed a significant short-term learning effect as illustrated in [Fig. 2](#f0010){ref-type="fig"}.

Prior to *VAccApp* utilization and without looking at the WHO-ICV, 24.7% of parents (44/178) were able to answer all three sample questions correctly, compared to 63.5% after *VAccApp* utilization (*p* \< 0.0001). System Usability Scores ranged from 35 to the maximum score of 100, with an average score of 69.6 ([Table 4](#t0020){ref-type="table"}).

4. Discussion {#s0060}
=============

Vaccines are powerful tools for disease prevention ([@bb0085]). With vaccine hesitancy on the rise, parents are seeking reliable information helping them to distinguish fact from fiction ([@bb0100], [@bb0355]). The active involvement of parents in matters of vaccine prevention may contribute towards restoring trust ([@bb0285], [@bb0105], [@bb0270]). Many parents have difficulties recalling the vaccination status of their child, which was shown by several studies earlier and confirmed by the current evaluation ([@bb0230], [@bb0225]). Parents need encouragement and support when keeping track of the vaccination record of their children ([@bb0360], [@bb0385]). This may be particularly important in larger families with many children ([@bb0060], [@bb0240], [@bb0295], [@bb0010], [@bb0275]). Current vaccination records however, are not designed to be used or understood by lay people.

Technical innovation may help parents to understand the vaccination status of their children. The *VAccApp* guides parents through the paper record allowing them to store the data for themselves in an easily accessible format. In this validation study, the App was user-tested by parents who were waiting for their child to be seen at an academic children\'s hospital in Germany. Use of the *VAccApp* motivated parents to take a closer look at the vaccination record of their children, often for the first time. It may be encouraging to doctors and patients alike, that *VAccApp* users were able to complete 95% of vaccine questions in the App correctly. A total of 62% responded to 100% of the questions correctly, thereby providing a complete and accurate vaccination history. These results indicate that with the help of the WHO-ICV and the *VAccApp*, the majority of parents are able to understand and interpret the vaccination history of their children accurately.

The reported validation project aims to test the functionality and feasibility of the *VAccApp* in a typical user group, with the limitation of a convenience sample derived from a single center. The QM project was not designed or powered to assess differences between subpopulations. It is possible that parents who remembered to bring the vaccination records to the emergency room also showed a greater interest in keeping their child\'s vaccinations up to date. Using the *VAccApp* will always require a minimum level of interest in the topic of vaccines and immunization. The *VAccApp* was decisively *not* designed as a substitute vaccination record, but as a helpful tool and encouragement for parents to take an active part in keeping their children healthy. Since the validation study was embedded in a QM program, randomization was not possible. Evidently, those parents who did not bring the vaccination record with them, could not have been asked to enter data from an absent vaccination record. Instead, they proceeded with verbal immunization histories as per standard of care.

The goal of this study was to study the ability of parents to understand the content of a standard vaccination record with the help of a mobile application. The results were compared to professional data entry into a standard clinical database using a copy of the same vaccination record.

The Recall Group served as a reminder that the quality of the information gained with verbal immunization histories (which are common practice) is in fact, very low. Minor demographic differences were observed: *VAccApp* users had younger children on average compared to the Recall Group. Younger children are vaccinated frequently, thus parents may be more likely to remember bringing the vaccination record with them to a doctor\'s visit.

The *VAccApp* can provide an important service with reminders for booster immunizations and motivating parents to remain well informed about the vaccination status of their children. The visual clues of the App help parents to see where they are in the process, to keep appointments and to prevent unnecessary delays in immunizations ([@bb0150], [@bb0170], [@bb0370], [@bb0325]). At the same time parents generate important information to be stored on their smartphones, which may be helpful at any time when the vaccination record may not be at hand. In the future, it will be important to engage older children and adolescents to learn more about their own health and vaccination status. Future studies evaluating the *VAccApp* in schools or adolescent clinics are currently being developed. Additional multi-center validation studies assessing differences in various settings, geographic regions and population strata, are planned. For those using regular telephones rather than smartphones, the *VAccApp* could be made available online for password-protected data entry via short message service or public computers.

While it would always be recommended for parents to bring the vaccination record to the hospital, this was the case in only 26% of parents in our setting. In Europe, parents may not be aware of their responsibly in this regard, unless their pediatrician has encouraged them to get involved in keeping vaccinations up-to-date.

In our validation setting, parents in the Recall Group were most likely to remember travel and special indication vaccines. This may be due to the fact that "exotic" vaccines require active decision-making on behalf of the parent, for example prior to taking a vacation in an exotic destination ([@bb0035], [@bb0135], [@bb0090], [@bb0030], [@bb0140]).

If the vaccination status was requested consistently during every doctor\'s visit, parents would grow accustomed to taking the vaccination record with them, including in stressful situations. This is evident from the ability of parents to remember the tetanus vaccination status better than other routine childhood vaccines, possibly due to the 'positive reinforcement' and frequent questioning by surgeons ([@bb0140]). Parents in this validation setting responded to vaccine-related questions while waiting for their children to be seen in the pediatric ED. This is also the "natural" setting where immunization data are relevant and when parents are likely to be motivated to learn about the vaccines protecting their children.

In many countries including in the US, the responsibility of maintaining vaccination records remains with the physician, the school system, or public health institutions, as would be the case with national or regional vaccination registries ([@bb0230], [@bb0220], [@bb0095]). Parents who are interested to create their own, portable vaccination record for their children, may take photos of the vaccination record to keep it in their smartphones.

While the accuracy of vaccination data may be higher with this approach, the *VAccApp* project was intentionally designed to empower parents to keep track of vaccinations in their family and to ask clarifying questions during the doctor\'s visit, rather than delegating the entire task to the healthcare provider ([@bb0330]).

The design of the *VAccApp* was a strength, as it was assessed by parents in the System Usability Survey. This may be due to an appealing user surface and the interaction with avatars. Completing the record in the *VAccApp* for the first time can be time consuming, as it required around 30 min. The time may be readily available and well-spent during waiting hours in the ED. Future vaccinations can be added later within a few minutes. Parents will be able to create one vaccine and risk factor profile per child, which can be linked through a common login for the entire family. Currently, the *VAccApp* assesses the vaccination status for 25 different vaccines, updates will be necessary for newly recommended vaccines. The *VAccApp* is available in German language, and translation into multiple additional languages is underway. The *VAccApp* will also need to be adjusted to accommodate different vaccination schedules across Europe and beyond.

The *VAccApp* validation provides useful insight on how the accuracy rate of 62% could be improved further: Routine childhood vaccination data are usually provided in a matrix format in the WHO-ICV ([Fig. 3](#f0015){ref-type="fig"}a), which appeared self-explanatory to most parents. Pages in the WHO-ICV where vaccines were listed individually (meningococcal vaccines for example, see [Fig. 3](#f0015){ref-type="fig"}b; [Table 3](#t0015){ref-type="table"}) were more likely to induce errors.

Additional guidance may be helpful. Future versions will provide "need clarification" signifiers reminding the parent to ask clarifying questions during upcoming physician visits, thereby improving data quality over time ([@bb0155]). The learning effect with the initial version of the *VAccApp* showed promise for future developments.

The *VAccApp* is in full compliance with Clinical Data Interchange Standards Consortium (CDISC) data standards, including the Clinical Data Acquisition Standards Harmonization (CDASH), the Biomedical Research Integrated Domain Group (BRIDG) Model and the Study Data Tabulation Model (SDTM), thereby meeting regulatory requirements ([@bb0220], [@bb0340], [@bb0115], [@bb0145], [@bb0075]). This will be useful if *VAccApp* entries are used in clinical trials, as well as safety and effectiveness studies. It also ensures Health Insurance Portability and Accountability Act (HIPPAA) compliance and data interoperability ([@bb0220], [@bb0110], [@bb0050], [@bb0015], [@bb0125]). Eventually, the user should be able to choose whether data are stored locally on the personal device or saved in a cloud system, if so desired ([@bb0055]).

Several vaccine-related mobile applications are under development, e.g. the "Vaccine Record for Travellers" in Australia ([@bb0235]), "ImmunizeCA" in Canada ([@bb0065], [@bb0410], [@bb0020]), and "myViavac" in Switzerland ([@bb0345]). The majority of these applications issue reminders for immunization appointments (e.g. "Save The Date" ([@bb0260]), "Vaximate" ([@bb0300])), or provide vaccine information (e.g. "Shots Immunizations" (Society of Teachers of Family Medicine ([@bb0335]), "Vaccines on the go" ([@bb0380])).

The *VAccApp* has an entirely different focus and represents the first user-centered education and empowerment tool allowing parents to understand the content of the vaccination record in addition to storing the data in a safe place. Well-informed parents who support and maintain vaccination records will have an improved sense of control and the ratification of playing an active role in keeping their children healthy ([@bb0105], [@bb0360], [@bb0385], [@bb0185]). Parents, who have an active interest in vaccinations, will likely encourage their peers to do the same, thereby improving public knowledge and appreciation of immunization programs ([@bb0420], [@bb0120]).

5. Conclusions {#s0065}
==============

Informed parents are more likely to appreciate the benefits of vaccines. With patient-reported outcomes becoming increasingly relevant to regulators, user-centered mobile applications may help to shift the attention to the vaccine recipient. The learning effect of digital vaccination apps could be further improved by providing additional feedback-loops for vaccine follow-ups this generating additional data sources for the monitoring of vaccine safety in real-time ([@bb0200], [@bb0290]). With children and adolescents representing the next generation of parents and caretakers, it will be important to develop age-appropriate forms of vaccine communication ([@bb0195]). Digital vaccination records will be easily accessible to adolescents and young adults, who rarely seek physician appointments ([@bb0350], [@bb0400], [@bb0165], [@bb0180], [@bb0070], [@bb0005]). Innovative visual language, based on gender and ethnic equality, is key to patient-driven vaccine communication.
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![Example of the *VAccApp* user interface.](gr1){#f0005}

![Pre/post testing illustrating short-term learning effects.\
Short-term learning effects are illustrated before and immediately after use of the *VAccApp*: pre/post testing questions are displayed separately with regards to tetanus, *Haemophilus influenzae* type b, and hexavalent vaccine.](gr2){#f0010}

###### 

The WHO International Certificate of Vaccination or Prophylaxis (WHO-ICV).

Routine childhood vaccines (such as poliomyelitis vaccine) are presented in a matrix format (a). Other vaccinations (such as hepatitis A vaccine) are documented in a list format (b), which appears to be more difficult for parents to read.
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###### 

Participant characteristics.

Table 1

  -------------------------------------------------------------------------------------------------------------------------
  Patient characteristics                                VAccApp Group        Recall Group   *p*-Value          
  ------------------------------------------------------ -------------------- -------------- ------------------ -----------
  Age of the child\                                      38.7                 82.1           **\<** **0.001**   
  (mean in months) range                                                                                        

  \(2180\)                                               \(2216\)                                               

  Gender (% male)                                        56.2                 49.3           0.151              

  First or second generation international migrant (%)   51.1                 52.9           0.708              

  Race (%)                                               Caucasian or White   83.1           75.2               **0.046**

  Middle Eastern or North African                        10.1                 13.7           0.254              

  African American or Black                              2.2                  3.2            0.529              

  Asian                                                  2.2                  2.5            0.838              

  Native Hawaiian or other Pacific Islander              0.0                  0.4            0.399              

  Other                                                  0.6                  0.7            0.898              

  Unidentified                                           1.7                  4.3            0.129              

  Ethnicity (%)                                          Hispanic or Latino   1.1            0.7                0.651

  Non-Hispanic or Latino                                 96.6                 92.1           0.051              

  Other                                                  1.1                  2.2            0.385              

  Unidentified                                           1.1                  5.0            0.027              

  Number of individuals living in household (mean)       3.7                  3.9            0.140              

  Birth rank of the child among siblings (mean)          1.6                  1.7            0.501              
  -------------------------------------------------------------------------------------------------------------------------

Baseline characteristics of patients in the *VAccApp* Group (*n* = 178) compared to the Recall Group (*n* = 278). *p*-Values were computed using the Whitney *U* test and the Chi-square test to assess whether the groups were significantly different from each other. Boldface indicates statistical significance (*p* \< 0.05). The evaluation project was conducted between 2012 and 2014 in Berlin, Germany.

###### 

Vaccine-specific accuracy rates in the Recall Group.

Table 2

                                                        Vaccine type   Accurate responses in the Recall Group (%)
  ----------------------------------------------------- -------------- --------------------------------------------
  Routine childhood vaccines                            Tetanus        41.01
  Diphtheria                                            35.97          
  Polio                                                 35.25          
  Pertussis                                             35.25          
  Haemophilus influenzae type b                         29.86          
  Hepatitis B                                           31.29          
  Mumps                                                 39.21          
  Measles                                               39.21          
  Rubella                                               38.85          
  Pneumococcus                                          24.10          
  Meningococcus                                         23.74          
  Varicella                                             30.94          
  Rotavirus                                             38.13          
  Human papilloma virus                                 43.53          
  Special indication vaccines or passive immunization   Influenza      69.06
  Hepatitis A                                           38.85          
  Tick-born encephalitis                                42.81          
  RSV (palivizumab)                                     43.17          
  Tuberculosis                                          41.01          
  Typhoid fever                                         42.45          
  Yellow fever                                          42.09          
  Rabies                                                42.81          
  Cholera                                               42.81          
  Japanese encephalitis                                 42.81          
  Small pox                                             42.09          

Vaccine-specific accuracy rates describe the percentage of parents providing accurate vaccine-specific responses by recall only, i.e. without the vaccination record at hand (*n* = 278). Professional data entry from the original vaccination record served as gold standard. RSV = respiratory syncytial virus (passive immunization).

###### 

Vaccine-specific accuracy rates in the *VAccApp* Group.

Table 3

                                                        Vaccine type   Accurate responses in the *VAccApp* Group (%)
  ----------------------------------------------------- -------------- -----------------------------------------------
  Routine childhood vaccines                            Tetanus        96.07
  Diphtheria                                            94.38          
  Polio                                                 93.82          
  Pertussis                                             93.82          
  Haemophilus influenzae type b                         91.01          
  Hepatitis B                                           93.82          
  Mumps                                                 89.89          
  Measles                                               91.01          
  Rubella                                               92.13          
  Pneumococcus                                          90.45          
  Meningococcus                                         85.39          
  Varicella                                             91.57          
  Rotavirus                                             97.75          
  Human papilloma virus                                 99.44          
  Special indication vaccines or passive immunization   Influenza      93.26
  Hepatitis A                                           97.19          
  Tick-born encephalitis                                98.88          
  RSV (palivizumab)                                     96.07          
  Tuberculosis                                          98.31          
  Typhoid fever                                         100.00         
  Yellow fever                                          99.44          
  Rabies                                                100.00         
  Cholera                                               100.00         
  Japanese encephalitis                                 100.00         
  Small pox                                             99.44          

Vaccine-specific accuracy rates describe the percentage of parents providing accurate vaccine-specific responses when entering data from the original vaccination record into the *VAccApp* (*n* = 178). Professional data entry from the original vaccination record served as gold standard. RSV = respiratory syncytial virus (passive immunization).

###### 

Results of the system usability assessment.

Table 4

  System Usability Scale                                                                         Mean value on Likert scale (1-strongly disagree; 5-strongly agree)
  ---------------------------------------------------------------------------------------------- --------------------------------------------------------------------
  \#1: I think that I would like to use this app frequently.                                     3.57
  \#2: I found the app unnecessarily complex.                                                    2.29
  \#3: I thought the app was easy to use.                                                        3.89
  \#4: I think that I would need the support of a technical person to be able to use this app.   1.87
  \#5: I found the various functions in this app were well integrated.                           3.70
  \#6: I thought there was too much inconsistency in this app.                                   2.03
  \#7: I would imagine that most people would learn to use this app very quickly.                3.41
  \#8: I found the app very cumbersome to use.                                                   2.48
  \#9: I felt very confident using the app.                                                      3.74
  \#10: I needed to learn a lot of things before I could get going with this app.                1.81

After using the *VAccApp* for the first time, users were asked to assess the usability of the *VAccApp*, using the System Usability Scale ([@bb0040], [@bb0025]). The assessment resulted in an overall System Usability Score of 69.5 out of possible 100 points, individual scores ranging between 35 and 100.
